PDE7A and breast ductal adenocarcinoma: To identify such cancer-specific liabilities, we analyzed patient-derived ductal breast carcinoma samples for the expression of PDEs and identified significant overexpression of PDE7A mRNA in patient-derived ductal breast carcinoma samples compared to normal breast tissues (Figures 1A and S1A).